The Ensign Group, Inc. $ENSG Shares Bought by ABN AMRO Bank N.V.

ABN AMRO Bank N.V. raised its stake in shares of The Ensign Group, Inc. (NASDAQ:ENSGFree Report) by 68.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,019 shares of the company’s stock after purchasing an additional 5,298 shares during the period. ABN AMRO Bank N.V.’s holdings in The Ensign Group were worth $2,293,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of The Ensign Group by 9.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi boosted its holdings in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. increased its stake in The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares in the last quarter. Institutional investors and hedge funds own 96.12% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ENSG shares. Wall Street Zen raised The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. UBS Group set a $230.00 price target on The Ensign Group and gave the stock a “buy” rating in a research report on Friday, February 6th. Weiss Ratings reissued a “buy (b)” rating on shares of The Ensign Group in a research note on Tuesday, April 21st. Truist Financial set a $215.00 price objective on The Ensign Group and gave the company a “hold” rating in a report on Friday, February 6th. Finally, Zacks Research cut shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, The Ensign Group currently has an average rating of “Moderate Buy” and a consensus target price of $216.75.

Get Our Latest Stock Report on The Ensign Group

The Ensign Group Trading Down 1.2%

ENSG opened at $169.41 on Tuesday. The firm has a market capitalization of $9.90 billion, a price-to-earnings ratio of 27.59, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The company’s 50 day simple moving average is $198.46 and its two-hundred day simple moving average is $189.14. The Ensign Group, Inc. has a 1-year low of $134.79 and a 1-year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56.

The Ensign Group (NASDAQ:ENSGGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The business had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period in the prior year, the business earned $1.52 earnings per share. The business’s revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Analysts expect that The Ensign Group, Inc. will post 6.79 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were issued a $0.065 dividend. This represents a $0.26 annualized dividend and a yield of 0.2%. The ex-dividend date was Tuesday, March 31st. The Ensign Group’s dividend payout ratio is presently 4.23%.

Insider Buying and Selling

In related news, VP Beverly B. Wittekind sold 500 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $210.23, for a total value of $105,115.00. Following the completion of the sale, the vice president owned 32,779 shares of the company’s stock, valued at approximately $6,891,129.17. This represents a 1.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $182.21, for a total transaction of $127,547.00. Following the sale, the director owned 22,052 shares of the company’s stock, valued at approximately $4,018,094.92. The trade was a 3.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 4,242 shares of company stock valued at $862,154 over the last 90 days. Insiders own 4.00% of the company’s stock.

The Ensign Group Company Profile

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Featured Stories

Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSGFree Report).

Institutional Ownership by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.